These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2146876)
1. Second trimester maternal serum pregnancy specific beta-1 glycoprotein (SP-1) levels in normal and Down syndrome pregnancies. Petrocik E; Wassman ER; Lee JJ; Kelly JC Am J Med Genet; 1990 Sep; 37(1):114-8. PubMed ID: 2146876 [TBL] [Abstract][Full Text] [Related]
2. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA; Spencer K; Abushoufa RA Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome. Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896 [TBL] [Abstract][Full Text] [Related]
5. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG. Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Hsu JJ; Hsieh TT; Soong YK; Spencer K Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893 [TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
9. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome. Lehavi O; Aizenstein O; Evans MI; Yaron Y Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504 [TBL] [Abstract][Full Text] [Related]
10. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Spencer K; Bindra R; Cacho AM; Nicolaides KH Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947 [TBL] [Abstract][Full Text] [Related]
12. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509 [TBL] [Abstract][Full Text] [Related]
13. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies. Weinans MJ; Pratt JJ; de Wolf BT; Mantingh A Prenat Diagn; 2001 Sep; 21(9):723-5. PubMed ID: 11559906 [TBL] [Abstract][Full Text] [Related]
14. Serum leptin in first-trimester Down syndrome pregnancies. Hedley P; Christiansen M Prenat Diagn; 2008 Jun; 28(6):475-7. PubMed ID: 18437707 [TBL] [Abstract][Full Text] [Related]
15. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
16. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244 [TBL] [Abstract][Full Text] [Related]
17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Spencer K Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030 [TBL] [Abstract][Full Text] [Related]
18. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325 [TBL] [Abstract][Full Text] [Related]
19. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester. Christiansen M; Nørgaard-Pedersen B Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984 [TBL] [Abstract][Full Text] [Related]
20. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]